Amyloidosis, Familial
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant (NCT03862807) | Alnylam Pharmaceuticals | 2019-03-27 |
Track Amyloidosis, Familial automatically
Every clearance here is in the API, with alerts when new ones post.